Improving Outcome of Thalassemia with Hematopoetic Stem Cell Transplantation: An Experience of Gujarat Cancer Research Institute.

Autor: Raut S; GCRI, Ahmedabad, Gujarat., Shah S; GCRI, Ahmedabad, Gujarat., Shah K; GCRI, Ahmedabad, Gujarat., Patel K; GCRI, Ahmedabad, Gujarat., Talati S; GCRI, Ahmedabad, Gujarat., Parikh S; GCRI, Ahmedabad, Gujarat., Anand A; GCRI, Ahmedabad, Gujarat., Panchal H; GCRI, Ahmedabad, Gujarat., Patel A; GCRI, Ahmedabad, Gujarat.
Jazyk: angličtina
Zdroj: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion [Indian J Hematol Blood Transfus] 2016 Sep; Vol. 32 (3), pp. 284-91. Date of Electronic Publication: 2015 Aug 02.
DOI: 10.1007/s12288-015-0576-4
Abstrakt: Total 26 children of thalassemia underwent hematopoetic stem cell transplantation from September 2006 to December 2014. Out of these 17 were matched sibling transplantation (MST) and 9 were unrelated umbilical cord blood transplantation (UCT). Median age was 4 years. At a median follow up of 46.5 months, 12 of 17 (70 %) MST and 3 out of 9 (33.33 %) UCT were cured of thalassemia. Three (11.53 %) patients died due to transplant related mortality. Average cost of MST was 6 lakhs and that of UCT was 20 lakhs.
Databáze: MEDLINE
Externí odkaz: